Abstract
The incidence of heparin-induced thrombocytopenia (HIT) types I and II was investigated retrospectively in 500 heparin-treated patients. In our department of internal medicine 500 patients were treated with unfractionated, middle- or low-molecular heparin (s.c. or i.v.) during 1995 as inpatients. Excluded were patients with other known causes of thrombocytopenia. There were 306 females (61%), mean age 76 years (17–98 years) and 194 males (39%), mean age 73 years (24–93 years). The incidence of HI type I was 4.4% and of HIT type II 0.6% with a positive heparin-induced-platelet-activation test (HIPA test). In addition, HIT type II was suspected in another 1.4% of cases with negative or missing HIPA test. Because of our results on the incidence of HIT type I and type II a close control of thrombocyte count during heparin therapy is necessary. In the case of HIT type II disease, heparin therapy must be stopped immediately.
Similar content being viewed by others
References
Chong BH, Berndt MC (1989) Heparin-induced thrombocytopenia. Blut 58:53–57.
Chong BH, Fawaz I, Chesterman CN, Berndt MC (1989) Heparin-induced thrombocytopenia. Mechanism of interaction of the heparin-dependent antibody with platelets. Br J Haematol 73:235–240.
King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100:535–540.
Towe JB, Bernhard VM, Hussey C, Garancis JC (1979) White clot syndrome. Arch Surg 114:372–377.
Bell WR, Tomasula PA, Alving BM, Duffy PT (1976) Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med 85:155–160.
Bauriedel G, Gerbig H, Riess H, Samtleben W, Steinbeck G (1988) Heparin-induzierte Thrombozytopenie. Münch Med Wschr 130:133–134.
Greinacher A, Müller-Eckhardt C (1991) Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wschr 116:1479–1482.
Greinacher A, Michels I, Kiefel V, Müller-Eckhardt C (1991) A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemostas 66:734–736.
Hach-Wunderle V, Nawroth PP (1995) Lebensbedrohliche Gerinnungsstörungen in der Intensivmedizin. Springer-Verlag: New York, pp 71–77.
Kelton JG, Sheridan D, Santos A, et al. (1988) Heparin-induced thrombocytopenia. Laboratory studies. Blood 72:925–930.
Killer S, Zoppi M, Künzi UP, et al. (1995) Heprininduzierte Thrombozytopenie (HIT). Schweiz Med Wschr 125:2518–2522.
Singer RL, Mannion JD, Bauer TL, Armenti FR, Edie RN (1993) Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest 104:1436–1440.
Spadone D, Clark F, James E, Laster J, Hoch J, Silver D (1992) Heparin-induced thrombocytopenia in the newborn. J Vasc Surg 15:306–312.
Walls JT, Boley TM, Curtis JJ, Silver D (1992) Heparin-induced thrombocytopenia in patients undergoing intraaortic balloon pumping after open heart surgery. ASAIO J: 574–576.
Walls JT, Curtis JJ, Silver D, Boley TM (1990) Heparin-induced thrombocytopenia in patients who undergo open heart surgery. Surgery 108:686–692.
Warkentin TE, Levine MN, Hirsh J, et al. (1995) Heparin-induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 322:1330–1335.
Greinacher A, Michels I, Müller-Eckhardt C (1992) Heparin-associated thrombocytopenia. The antibody is not heparin specific. Thrombos Haemost 67:545–549.
Greinacher A (1996) Heparin-induzierte Thrombozytopenie. Internist 37:1172–1178.
Garcia S, Cervero A, Sanchez M, Colomina P (1991) heparin-associated thrombocytopenia in a patient with polycythemia vera. The importance of a marked drop in platelet count. Acta Haematol 85:169–170.
Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Poetzsch B (1994) Heparin-associated thrombosis despite normal platelet counts (letter). Lancet 13344:469–470.
Chong BH, Pilgrim RL, Cooley MA, Chesterman CN (1993) Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia. Blood 81:988–993.
Greinacher A, Amiral J, Dummel V, Vissac AM, Kiefel V, Müller-Eckhardt C (1994) Laboratory diagnosis of heparin-associated thrombocytopenia, comparison of platelet activation (HIPA) test, and PF4/heparin ELISA. Transfusion 34:381–385.
Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme G, Horsewood P (1995) IgG from patients with heparin-induced thrombocytopenia bind to a complex of heparin and platelet factor 4. Blood.
Magnani HN (1993) Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 70:554–561.
Author information
Authors and Affiliations
About this article
Cite this article
Kahl, K., Heidrich, H. The incidence of heparin-induced thrombocytopenias. International Journal of Angiology 7, 255–257 (1998). https://doi.org/10.1007/BF01617406
Issue Date:
DOI: https://doi.org/10.1007/BF01617406